Labyrinth Devices MVI™ Multichannel Vestibular Implant System

DEVICE3 trials

Sponsors

Johns Hopkins University

Conditions

Aminoglycoside OtotoxicityAminoglycoside ToxicityBilateral Vestibular DeficiencyBilateral Vestibular Deficiency (BVD)Bilateral Vestibular HypofunctionBilateral VestibulopathyGentamicin OtotoxicityLabyrinth Diseases

Unknown Phase

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

RecruitingNCT05674786

Johns Hopkins UniversityAminoglycoside Ototoxicity, Bilateral Vestibular Deficiency (BVD), Bilateral Vestibular Hypofunction +6

Start: 2023-02-28End: 2027-03-31Target: 8Updated: 2026-01-12

Vestibular Implantation in Older Adults

RecruitingNCT05676944

Johns Hopkins UniversityAminoglycoside Ototoxicity, Bilateral Vestibular Deficiency (BVD), Bilateral Vestibular Hypofunction +7

Start: 2023-04-11End: 2028-01-31Target: 15Updated: 2026-01-12

Long Term Outcomes After Vestibular Implantation

RecruitingNCT06500975

Johns Hopkins UniversityAminoglycoside Toxicity, Bilateral Vestibular Deficiency, Bilateral Vestibular Hypofunction +6

Start: 2024-12-01End: 2029-12-01Target: 32Updated: 2026-03-09